Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali

Background. In 2010, mass vaccination with a then-new meningococcal A polysaccharide–tetanus toxoid protein conjugate vaccine (PsA-TT, or MenAfriVac) was undertaken in 1- to 29-year-olds in Bamako, Mali. Whether vaccination with PsA-TT effectively boosts tetanus immunity in a population with heterog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Infect Dis
Autors principals: Basta, Nicole E., Borrow, Ray, Berthe, Abdoulaye, Onwuchekwa, Uma, Dembélé, Awa Traoré Eps, Almond, Rachael, Frankland, Sarah, Patel, Sima, Wood, Daniel, Nascimento, Maria, Manigart, Olivier, Trotter, Caroline L., Greenwood, Brian, Sow, Samba O.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2015
Matèries:
The Meningitis Vaccine Project: The Development, Licensure, Introduction, and Impact of a New Group a Meningococcal Conjugate Vaccine for Africa
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4639490/
https://ncbi.nlm.nih.gov/pubmed/26553691
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/civ513
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars